1. Home
  2. JMIA vs PHAR Comparison

JMIA vs PHAR Comparison

Compare JMIA & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jumia Technologies AG each representing two

JMIA

Jumia Technologies AG each representing two

HOLD

Current Price

$6.82

Market Cap

852.1M

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$13.42

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JMIA
PHAR
Founded
2012
1988
Country
Germany
Netherlands
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
852.1M
1.0B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
JMIA
PHAR
Price
$6.82
$13.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$16.75
$38.33
AVG Volume (30 Days)
1.6M
5.1K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.18
$10.04
Revenue Next Year
$23.26
$2.51
P/E Ratio
N/A
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$4.23
$9.54
52 Week High
$14.72
$21.34

Technical Indicators

Market Signals
Indicator
JMIA
PHAR
Relative Strength Index (RSI) 48.46 46.14
Support Level $6.45 $12.88
Resistance Level $7.59 $13.61
Average True Range (ATR) 0.35 0.54
MACD 0.02 0.03
Stochastic Oscillator 52.26 20.32

Price Performance

Historical Comparison
JMIA
PHAR

About JMIA Jumia Technologies AG each representing two

Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace that connects sellers with consumers. The logistics services of the company enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. The company generates revenue from first-party sales, third-party sales, marketing and advertising, and the provision of other services. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates majority of its revenue from the West Africa segment.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: